Cornerstone Management Inc. Sells 14,953 Shares of Globe Life Inc. $GL

Cornerstone Management Inc. decreased its position in Globe Life Inc. (NYSE:GL) by 63.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,736 shares of the company’s stock after selling 14,953 shares during the period. Globe Life makes up 0.2% of Cornerstone Management Inc.’s holdings, making the stock its 28th biggest holding. Cornerstone Management Inc.’s holdings in Globe Life were worth $1,249,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Global Assets Advisory LLC acquired a new position in shares of Globe Life in the 2nd quarter valued at about $25,000. AdvisorNet Financial Inc increased its holdings in Globe Life by 60.0% in the second quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock worth $28,000 after purchasing an additional 84 shares in the last quarter. CYBER HORNET ETFs LLC bought a new stake in Globe Life in the second quarter worth approximately $28,000. Assetmark Inc. lifted its stake in Globe Life by 777.8% in the second quarter. Assetmark Inc. now owns 237 shares of the company’s stock valued at $29,000 after buying an additional 210 shares during the period. Finally, MUFG Securities EMEA plc bought a new position in shares of Globe Life during the 2nd quarter worth approximately $31,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Stock Performance

GL opened at $139.37 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. The company’s fifty day moving average price is $134.24 and its two-hundred day moving average price is $133.16. Globe Life Inc. has a 1-year low of $105.46 and a 1-year high of $147.83. The company has a market cap of $11.10 billion, a price-to-earnings ratio of 10.10 and a beta of 0.48.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.54 by $0.27. The firm had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.52 billion. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. During the same period last year, the company earned $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. On average, analysts expect that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Monday, January 5th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Monday, January 5th. Globe Life’s payout ratio is currently 7.83%.

Insider Buying and Selling

In other news, CEO Frank M. Svoboda sold 9,379 shares of the stock in a transaction that occurred on Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total value of $1,317,092.97. Following the completion of the sale, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at $5,036,943.24. This represents a 20.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.51% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on GL shares. TD Cowen lifted their price objective on shares of Globe Life from $182.00 to $199.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Piper Sandler restated an “overweight” rating and issued a $167.00 price target on shares of Globe Life in a report on Friday, November 21st. Keefe, Bruyette & Woods lifted their price target on shares of Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a research note on Tuesday, October 28th. Morgan Stanley reiterated an “overweight” rating and set a $176.00 price objective on shares of Globe Life in a report on Monday, December 15th. Finally, Truist Financial increased their price objective on shares of Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a research report on Friday, October 24th. Nine equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and an average price target of $164.89.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.